These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 19185524)

  • 1. Structural basis for recognition of diubiquitins by NEMO.
    Lo YC; Lin SC; Rospigliosi CC; Conze DB; Wu CJ; Ashwell JD; Eliezer D; Wu H
    Mol Cell; 2009 Mar; 33(5):602-15. PubMed ID: 19185524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct inhibition of NF-κB activation by peptide targeting the NOA ubiquitin binding domain of NEMO.
    Chiaravalli J; Fontan E; Fsihi H; Coic YM; Baleux F; Véron M; Agou F
    Biochem Pharmacol; 2011 Nov; 82(9):1163-74. PubMed ID: 21803029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism underlying IκB kinase activation mediated by the linear ubiquitin chain assembly complex.
    Fujita H; Rahighi S; Akita M; Kato R; Sasaki Y; Wakatsuki S; Iwai K
    Mol Cell Biol; 2014 Apr; 34(7):1322-35. PubMed ID: 24469399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DARPin-assisted crystallography of the CC2-LZ domain of NEMO reveals a coupling between dimerization and ubiquitin binding.
    Grubisha O; Kaminska M; Duquerroy S; Fontan E; Cordier F; Haouz A; Raynal B; Chiaravalli J; Delepierre M; Israël A; Véron M; Agou F
    J Mol Biol; 2010 Jan; 395(1):89-104. PubMed ID: 19854204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The trimerization domain of NEMO is composed of the interacting C-terminal CC2 and LZ coiled-coil subdomains.
    Agou F; Traincard F; Vinolo E; Courtois G; Yamaoka S; Israël A; Véron M
    J Biol Chem; 2004 Jul; 279(27):27861-9. PubMed ID: 15107419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structure of the NEMO ubiquitin-binding domain in complex with Lys 63-linked di-ubiquitin.
    Yoshikawa A; Sato Y; Yamashita M; Mimura H; Yamagata A; Fukai S
    FEBS Lett; 2009 Oct; 583(20):3317-22. PubMed ID: 19766637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two-sided ubiquitin binding of NF-κB essential modulator (NEMO) zinc finger unveiled by a mutation associated with anhidrotic ectodermal dysplasia with immunodeficiency syndrome.
    Ngadjeua F; Chiaravalli J; Traincard F; Raynal B; Fontan E; Agou F
    J Biol Chem; 2013 Nov; 288(47):33722-33737. PubMed ID: 24100029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific recognition of linear ubiquitin chains by NEMO is important for NF-kappaB activation.
    Rahighi S; Ikeda F; Kawasaki M; Akutsu M; Suzuki N; Kato R; Kensche T; Uejima T; Bloor S; Komander D; Randow F; Wakatsuki S; Dikic I
    Cell; 2009 Mar; 136(6):1098-109. PubMed ID: 19303852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NF-κB essential modulator (NEMO) interaction with linear and lys-63 ubiquitin chains contributes to NF-κB activation.
    Hadian K; Griesbach RA; Dornauer S; Wanger TM; Nagel D; Metlitzky M; Beisker W; Schmidt-Supprian M; Krappmann D
    J Biol Chem; 2011 Jul; 286(29):26107-17. PubMed ID: 21622571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New mechanism of X-linked anhidrotic ectodermal dysplasia with immunodeficiency: impairment of ubiquitin binding despite normal folding of NEMO protein.
    Hubeau M; Ngadjeua F; Puel A; Israel L; Feinberg J; Chrabieh M; Belani K; Bodemer C; Fabre I; Plebani A; Boisson-Dupuis S; Picard C; Fischer A; Israel A; Abel L; Veron M; Casanova JL; Agou F; Bustamante J
    Blood; 2011 Jul; 118(4):926-35. PubMed ID: 21622647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure of a compact conformation of linear diubiquitin.
    Rohaim A; Kawasaki M; Kato R; Dikic I; Wakatsuki S
    Acta Crystallogr D Biol Crystallogr; 2012 Feb; 68(Pt 2):102-8. PubMed ID: 22281738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liquid phase separation of NEMO induced by polyubiquitin chains activates NF-κB.
    Du M; Ea CK; Fang Y; Chen ZJ
    Mol Cell; 2022 Jul; 82(13):2415-2426.e5. PubMed ID: 35477005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NEMO specifically recognizes K63-linked poly-ubiquitin chains through a new bipartite ubiquitin-binding domain.
    Laplantine E; Fontan E; Chiaravalli J; Lopez T; Lakisic G; Véron M; Agou F; Israël A
    EMBO J; 2009 Oct; 28(19):2885-95. PubMed ID: 19763089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for M1-Linked Polyubiquitin-Mediated Conformational Change in NEMO.
    Hauenstein AV; Xu G; Kabaleeswaran V; Wu H
    J Mol Biol; 2017 Dec; 429(24):3793-3800. PubMed ID: 29111346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NEMO oligomerization and its ubiquitin-binding properties.
    Ivins FJ; Montgomery MG; Smith SJ; Morris-Davies AC; Taylor IA; Rittinger K
    Biochem J; 2009 Jun; 421(2):243-51. PubMed ID: 19422324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of interaction between NEMO and SHARPIN impairs linear ubiquitination and NF-κB activation and leads to incontinentia pigmenti.
    Bal E; Laplantine E; Hamel Y; Dubosclard V; Boisson B; Pescatore A; Picard C; Hadj-Rabia S; Royer G; Steffann J; Bonnefont JP; Ursini VM; Vabres P; Munnich A; Casanova JL; Bodemer C; Weil R; Agou F; Smahi A
    J Allergy Clin Immunol; 2017 Dec; 140(6):1671-1682.e2. PubMed ID: 28249776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of NF-kappa B activation by peptides targeting NF-kappa B essential modulator (nemo) oligomerization.
    Agou F; Courtois G; Chiaravalli J; Baleux F; Coïc YM; Traincard F; Israël A; Véron M
    J Biol Chem; 2004 Dec; 279(52):54248-57. PubMed ID: 15466857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NMR reveals a different mode of binding of the Stam2 VHS domain to ubiquitin and diubiquitin.
    Lange A; Hoeller D; Wienk H; Marcillat O; Lancelin JM; Walker O
    Biochemistry; 2011 Jan; 50(1):48-62. PubMed ID: 21121635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural analysis of the UBA domain of X-linked inhibitor of apoptosis protein reveals different surfaces for ubiquitin-binding and self-association.
    Tse MK; Hui SK; Yang Y; Yin ST; Hu HY; Zou B; Wong BC; Sze KH
    PLoS One; 2011; 6(12):e28511. PubMed ID: 22194841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of NF-kappaB activation with designed ankyrin-repeat proteins targeting the ubiquitin-binding/oligomerization domain of NEMO.
    Wyler E; Kaminska M; Coïc YM; Baleux F; Véron M; Agou F
    Protein Sci; 2007 Sep; 16(9):2013-22. PubMed ID: 17766391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.